Physicians

Matthew R. Reynolds M.D, M.Sc.

Instructor in Medicine, Harvard Medical School
Arrhythmias, Quality of Life, Health Economics, Cost-Effectiveness

Research Description

Dr. Reynolds' research interests focus on studying the impact of new cardiovascular technologies on health care costs and quality of life. He is the recipient of a K23 mentored patient-oriented career development award from the National Heart, Lung, and Blood Institute. The purpose of the grant is to study the impact of radiofrequency catheter ablation and other interventions on health care costs and quality of life in patients with atrial fibrillation. He has also completed economic analyses related to coronary stenting, stent thrombosis, therapies for in-stent restenosis, and management strategies for atrial fibrillation, as well as a population wide outcomes study following cardioverter-defibrillator (ICD) implantation. Dr. Reynolds has served as Medical Director for HCRI's Economics and Quality of Life Assessment group since 2006.

Biography

Dr. Reynolds received his MD from the University of Pennsylvania and a Master of Science in Health Policy and Management from the Harvard School of Public Health. He is board certified in Internal Medicine, Cardiology and Clinical Cardiac Electrophysiology. In addition to his research activities, Dr. Reynolds holds a part-time clinical appointment in cardiac electrophysiology at the Boston VA Healthcare System, where he performs the full range of EP procedures, including implantation of pacemakers, ICDs and cardiac resynchronization devices; diagnostic EP studies, and catheter ablations. The Boston VA houses the only active EP service in New England.

Phone

617.632.1489

Address

Director, EQOL HCRI, Division of Cardiology, Beth Israel Deaconess Meical Center, 185 Pilgrim Road
Boston, MA 02215

Significant Publications

Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. Am J Cardiol. 2003;92(6):677-81.

Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol. 2007 Jun;18(6):628-33.

Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007 Aug 13-27;167(15):1648-53.

Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006 Feb 15;97(4):538-43.

The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006 Jun 20;47(12):2493-7.